The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self-administered ...
Rozanolixizumab self-administration was 100% successful, with patients preferring the manual push method over infusion pumps for its simplicity and cost-effectiveness. The study involved 55 patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results